HepG2 cells were treated with 1 mmol/l FFAs alone or together with compound 2 (25 µmol/l) for 24 h. Cells were lysed using radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology) containing 1 mmol/l phenylmethane sulfonylfluoride for 20 min on ice. Subsequently, cell lysates were centrifuged at 12,000 × g for 10 min at 4°C. The protein concentration was determined using a BCA protein assay kit (Beyotime Institute of Biotechnology). Equal amounts (40 µg) of extracted protein samples were separated by 15% SDS-PAGE and transferred onto a polyvinylidene fluoride membrane (EMD Millipore, Billerica, MA, USA). The membrane was blocked with 5% non-fat milk for 1 h at room temperature (~22°C), and then incubated with anti-GAPDH, anti-ERp57 and anti-FAS primary antibodies at 4°C overnight. Following washing three times with TBST (TBS containing 0.1% Tween-20; cat no. P0231; Beyotime Institute of Biotechnology), the membranes were incubated with horseradish peroxidase-conjugated goat anti-mouse and anti-rabbit IgG secondary antibodies at room temperature for 2 h. Protein bands were visualized by enhanced chemiluminescence using SuperSignal™ West Pico Chemiluminescent Substrate (Thermo Fisher Scientific, Inc.).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.